✦ LIBER ✦

Paraoxonase 1 Mutations in a Turkish Population

✍ Scribed by A.Sükrü Aynacioglu; Ingolf Cascorbi; Przemyslaw M. Mrozikiewicz; Muradiye Nacak; E.Ebru Tapanyigit; Ivar Roots

Book ID: 112266891
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 42 KB
Volume: 157
Category: Article
ISSN: 0041-008X
DOI: 10.1006/taap.1999.8690

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Age-Related Paraoxonase Activity Changes

✍ ERCAN SARUHAN; ABDULLAH OLGUN; KAMILE ÖZTÜRK; SERIF AKMAN; M. KEMAL ERBIL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

High frequency of CYP1A1 mutations in a

High frequency of CYP1A1 mutations in a Turkish population

✍ A. Sükrü Aynacioglu; Ingolf Cascorbi; Przemyslaw M. Mrozikiewicz; Ivar Roots 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 332 KB

CYP2D6 and CYP1A1 mutations in the Turki

CYP2D6 and CYP1A1 mutations in the Turkish population

✍ Muge Aydin; Ozden Hatirnaz; Nevin Erensoy; Ugur Ozbek 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 1 views

Serum paraoxonase and arylesterase activ

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population

✍ Emin T Elkiran; Nefsal Mar; Bilge Aygen; Ferit Gursu; Aziz Karaoglu; Suleyman Ko 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 306 KB

Paraoxonase 1 status in the Thai populat

Paraoxonase 1 status in the Thai population

✍ Wimon Phuntuwate; Chuthamanee Suthisisang; Banhan Koanantakul; Michael I Macknes 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 262 KB

Prothrombin gene 20210 G-A mutation in t

Prothrombin gene 20210 G-A mutation in the Turkish population

✍ Akar, Nejat; Misirlioglu, Müge; Akar, Ece; Avcu, Ferit; Yalçin, Atilla; Sözüöz, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

to permit rapid consideration for publication. ## Simultaneous Occurrence of Lupus Anticoagulant and Factor VIII Inhibitors in Hemophilia To the Editor: The letter published in the November 1997 issue, regarding simultaneous occurrence of lupus anticoagulant (LA) and factor VIII inhibitors [1,2],